Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines…
New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the…
Prostate Cancer Breakthroughs With Nuclear Medicine
KUALA LUMPUR, Sept 25 — When a 72-year-old patient found himself unable to enjoy even the simplest pleasures,…
Genomic testing speeds patient accrual in high-risk prostate cancer trial
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk…
Oncologist says ‘men over 50’ should never ignore these early warning signs of prostate cancer
Men’s health often takes a backseat until symptoms become hard to ignore. Ignoring early signs can have serious…